Jeffrey A. Bluestone, PhD

University of California, San Francisco

Dr. Bluestone holds the A.W. and Mary Margaret Clausen Distinguished Professorship in Metabolism and Endocrinology and is current Director of the Hormone Research Institute. He joined the University of California San Francisco (UCSF) faculty in 2000. In March 2010 he was appointed Executive Vice Chancellor and Provost (EVCP), to serve as chief academic officer guiding the research and academic enterprise at UCSF, advancing the campus priorities in collaboration with the Chancellor and campus leadership. Prior to his appointment as EVCP, Dr. Bluestone served as the Director of the UCSF Diabetes Center where he emphasized translating basic research in both type 1 and type 2 diabetes into improved therapies for patients. Dr. Bluestone founded and directed the Immune Tolerance Network, a consortium of more than 1,000 of the world’s leading scientific researchers and clinical specialists from nearly 50 institutions, with the mission of testing new therapies to promote immune tolerance in transplantation, autoimmune diseases, asthma and allergic diseases. As an international scientist and leader in the field of immunotherapy, his expertise has helped to clarify the body’s immune response on a molecular level, and has catalyzed recent progress in stem cell research, islet cell transplantation and immune tolerance therapies – studies that have been translated into drugs to treat human disease. Dr. Bluestone is a member of the American Academy of Arts and Sciences and holds numerous accolades for his achievements.